Streetbeat News

ZJYL

Jin Medical International Ltd.

https://www.zhjmedical.com

Industry

Medical - Instruments & Supplies

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

Open

0.76

Mkt cap

133M

Volume

264K

High

0.89

P/E Ratio

42.50

52-wk high

16.60

Low

0.76

Div yield

N/A

52-wk low

0.70

During Monday's intraday session, several healthcare stocks experienced significant movements. China SXT Pharmaceuticals (SXTC) saw a 91% increase, while RenovoRx (RNXT) and Jin Medical International (ZJYL) rose by 49.65% and 39.94%, respectively. Aditxt (ADTX), Celularity (CELU), and Ekso Bionics Holdings (EKSO) also saw substantial gains. Conversely, Cue Health (HLTH), SenesTech (SNES), Bone Biologics (BBLG), Processa Pharma (PCSA), Fortress Biotech (FBIO), and Cingulate (CING) experienced notable declines.

Portfolio Pulse from Benzinga Insights

January 01, 2024 | 5:30 pm

In Monday's pre-market session, several healthcare stocks experienced significant movements. Gainers included China SXT Pharmaceuticals (SXTC) with a 185.1% increase, cbdMD (YCBD) up by 62.04%, and Kintara Therapeutics (KTRA) rising by 48.91%. Aditxt (ADTX), Jin Medical International (ZJYL), and Elicio Therapeutics (ELTX) also saw notable gains. Conversely, Microbot Medical (MBOT), Cingulate (CING), Scinai Immunotherapeutics (SCNI), SenesTech (SNES), Fortress Biotech (FBIO), and Enveric Biosciences (ENVB) were among the losers, with declines ranging from 16.03% to 24.4%.

Portfolio Pulse from Benzinga Insights

January 01, 2024 | 1:05 pm

Fisker Inc. (NYSE:FSR) shares surged over 20% after the company reported a 300% increase in deliveries from Q3 to Q4, with total deliveries around 4,700, primarily of the Fisker Ocean One launch edition. Other stocks also showed significant movement in Friday's mid-day session, with notable gainers and losers across various sectors.

Portfolio Pulse from Avi Kapoor

December 29, 2023 | 6:03 pm

During Friday's intraday session, several healthcare stocks experienced significant movements. China SXT Pharmaceuticals (SXTC) saw a 108.8% increase, while cbdMD (YCBD) rose by 73.85%. Other gainers included Qilian Intl Hldg Gr (QLI), Aditxt (ADTX), RenovoRx (RNXT), and Jin Medical International (ZJYL). Conversely, Processa Pharma (PCSA), Bone Biologics (BBLG), Fortress Biotech (FBIO), Meihua Intl Medical Techs (MHUA), SenesTech (SNES), and Microbot Medical (MBOT) faced declines.

Portfolio Pulse from Benzinga Insights

December 29, 2023 | 5:31 pm

Jin Medical International Ltd. (NASDAQ:ZJYL) stock surged after receiving a letter from Nasdaq stating that the delisting action has been stayed pending a hearing decision. The company was previously notified of non-compliance with Nasdaq's public holders requirement and failed to provide a compliance plan. A hearing is scheduled for March 14, 2024. Additionally, Jin Medical signed an MOU for a potential acquisition of Jiangsu Zhongjin Kanglu Information Technology Co., Ltd. The company has a small float and a volatile stock price history.

Portfolio Pulse from Erica Kollmann

December 28, 2023 | 8:49 pm

Bone Biologics Corp (NASDAQ:BBLG) stock is experiencing high volatility and multiple trading halts without company-specific news. The stock underwent a 1-for-8 reverse split on Dec. 20 and closed a direct offering on Nov. 20. With a small float and high short interest, BBLG is moving with other small cap pharmaceutical stocks like ZJYL, TTOO, and IOVA. BBLG's borrow fee rate is 91.79%, and no shares are available to short. The stock is up 31% at $6.10.

Portfolio Pulse from Erica Kollmann

December 28, 2023 | 6:27 pm

Health care stocks experienced significant movement in Thursday's intraday session. Cingulate, SenesTech, Jin Medical International, Microbot Medical, Ocean Biomedical, and Bone Biologics saw their shares rise by 125.8%, 107.53%, 58.53%, 36.71%, 30.51%, and 27.53% respectively. Conversely, CytoSorbents, Bluejay Diagnostics, Meihua Intl Medical Techs, IMAC Hldgs, P3 Health Partners, and NeoGenomics witnessed declines in their share prices by 38.7%, 29.18%, 29.16%, 23.71%, 19.55%, and 18.49% respectively.

Portfolio Pulse from Benzinga Insights

December 28, 2023 | 5:31 pm

Jin Medical International Ltd. received a notice from Nasdaq for non-compliance with Listing Rule 5550(a)(3) due to insufficient public holders. The company failed to present a compliance plan, leading Nasdaq to initiate delisting procedures. Trading suspension is stayed pending a hearing on March 14, 2024, where the company must prove its ability to comply with listing requirements. Jin Medical is reviewing options to regain compliance.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 3:06 pm

RayzeBio, Inc. (RYZB) shares surged 100% after announcing its acquisition by Bristol Myers Squibb for $62.50 per share in cash, valuing the deal at $4.1 billion. Other stocks also moved significantly in Tuesday's mid-day session, with ARB IOT Group Limited (ARBB) and IMAC Holdings, Inc. (BACK) among the top gainers, while PARTS iD, Inc. (ID) and Milestone Pharmaceuticals Inc. (MIST) were among the top losers.

Portfolio Pulse from Avi Kapoor

December 26, 2023 | 6:48 pm

In Tuesday's intraday session, several healthcare stocks experienced significant movements. RayzeBio (RYZB) saw a 100.8% increase to $61.4 with a market cap of $3.6 billion. IMAC Hldgs (BACK) rose 74.02% to $4.21, and Gracell Biotechnologies (GRCL) went up by 59.93% to $9.9. Conversely, Milestone Pharmaceuticals (MIST) dropped 32.3% to $1.95, ENDRA Life Sciences (NDRA) fell 22.01% to $1.95, and Jin Medical International (ZJYL) declined by 18.51% to $111.67.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 5:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.